Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral low-dose amiodarone for prevention of atrial fibrillation after coronary artery bypass surgery
IRCT201207303799N4Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of amiodarone in Atrial fibrillation (AFib), sponsored by Tehran University of Medical Sciences. Started Aug 2012; status: completed.
02
Drugs
amiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on IRCT201207303799N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201207303799N4.